Gut Microbiota and Metabolic Profiles in HIV Patients with Fatty Liver Disease

A clinical study investigating gut microbiome and metabolic changes in people living with HIV (PLWH) who have metabolic dysfunction-associated fatty liver disease (MAFLD). The dataset is hosted on figshare, authored by HuiTing Liu, and was last updated on May 30, 2026. The global prevalence of MAFLD in PLWH is estimated at 34%.

Use Cases

• Analyzing associations between gut microbial composition and metabolic dysfunction based on the described patient cohort
• Investigating the role of HIV infection in fatty liver disease progression based on the study's focus
• Identifying potential microbial biomarkers for MAFLD in immunocompromised populations based on the described data

Strengths

• Dataset provides a specific global prevalence figure (34%) for MAFLD in PLWH.
• Focuses on a clinically relevant intersection of HIV and metabolic liver disease.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic or demographic bias inherent to the specific clinical study.

Provenance

Source

figshare

Collection Method

Likely collected as part of a clinical research study.

Freshness

Last updated 2026-05-30 15:18:58; freshness should be verified.